No Data
No Data
HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $25 Price Target
H.C. Wainwright Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright analyst Douglas Tsao maintains $Cabaletta Bio(CABA.US)$ with a buy rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 45.4%
We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
Evercore ISI Cuts Price Target on Cabaletta Bio to $15 From $25, Keeps Outperform Rating
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2